Saturday, August 8, 2020
The Hemp CBD Times. Every minute hemp cbd industry news.

Category: GW Pharmaceuticals


FDA approves GW Pharmaceuticals’ cannabis drug for new indication

CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical…

By hempcbdtimes , in Cannabidiol Cannabis Industry & Marijuana Business Briefs CBD Dravet syndrome Epidiolex Europe Cannabis Industry & Marijuana Business News FDA GW Pharmaceuticals International Marijuana Business News Lennox-Gastaut syndrome Medical Cannabis Industry & Recreational Marijuana Business News tuberous sclerosis complex U.S. Food and Drug Administration United States Cannabis Industry & Marijuana Business News , at August 3, 2020

DEA removes cannabis drug Epidiolex from controlled substances list

Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled…

By hempcbdtimes , in Cannabis Industry & Marijuana Business Briefs DEA Epidiolex FDA Featured Marijuana Business & Cannabis Industry News GW Pharmaceuticals International Marijuana Business News Marijuana Legalization and Regulatory News for Cannabis Businesses Medical Cannabis Industry & Recreational Marijuana Business News United States Cannabis Industry & Marijuana Business News , at April 7, 2020

Reading the Tea Leaves: Looking at the History of Hemp and CBD to Predict the Future

By Justin Walsh[1] It’s an exciting time to be in hemp and CBD! I have attended and spoken at several…

By hempcbdtimes , in Agricultural Act of 2014 CBD Controlled Substance Act (CSA) Drug & Cosmetics Act Drug Enforcement Administration (DEA) Food Food and Drug Administration (FDA) GW Pharmaceuticals Hemp Hemp Policy & Legal Marihuana Tax Act Orphan Drug status The 2018 Farm Bill U.S. Department of Agriculture (USDA) , at March 10, 2020